Meet Cygnus, the Swan, a high-flying constellation that looks like its namesake and has a rich mythological history.

The post Meet the Cygnus, the High-Flying Swan appeared first on Sky & Telescope.

Southwest Research Institute (SwRI) and St. Mary’s University have embarked on a groundbreaking collaboration aimed at revolutionizing the future of hydrogen storage technology. This joint venture seeks to develop a comprehensive, physics-based forecasting tool capable of predicting the degradation and long-term durability of titanium-iron (TiFe)-based metal hydride vessels. Leveraging a chemical and thermo-mechanical modeling framework, the project represents a significant leap forward in tackling one of the most persistent challenges in hydrogen storage materials science. This initiative is made possible through a $125,839 grant from the St. Mary’s-SwRI Technology and Applied Research (S²TAR) Program, designed to foster impactful research collaborations.

Metal hydrides are pivotal materials in the hydrogen energy landscape, serving as one of the few safe and compact solid-state options for hydrogen storage. These materials function by chemically binding hydrogen to metal lattices through chemisorption, effectively locking hydrogen atoms within the structure. Unlike high-pressure gaseous tanks or cryogenic liquid hydrogen storage, metal hydrides offer improved safety profiles and reduce energy-intensive requirements. However, despite these advantages, their widespread application is hindered by their limited durability and performance degradation resulting from repeated hydrogen absorption and desorption cycles.

At the heart of this ambitious research endeavor is the intricate problem of metal hydride vessel degradation. Over numerous charge and discharge cycles, physical changes ensue within the alloy powders comprising the metal hydride bed. These changes include fracturing of particles, densification of the powder bed, and mechanical stresses that collectively impair hydrogen storage capacity and vessel performance. Traditional evaluation methods rely heavily on prolonged, costly experimental testing to assess long-term vessel integrity—a bottleneck that impedes innovation and commercialization.

The project team, headed by Dr. Richard S. Fu of SwRI and Dr. Mohamed Shaat of St. Mary’s University, seeks to transcend these limitations by integrating advanced physics-based simulations with targeted experimental validation. This dual approach aims to create a robust modeling framework capable of forecasting the lifecycle and operational durability of TiFe metal hydride vessels. The predictive tool will account for the coupled chemical, thermal, and mechanical phenomena driving hydrogen cycling performance over hundreds or even thousands of cycles.

Dr. Shaat is spearheading the development of an intricate, multiphysics computational framework at St. Mary’s University. This model is designed to encapsulate the complex interplay between hydrogen diffusion, chemisorption reactions, phase transformations within the metal hydride, heat generation and transfer, and the evolution of mechanical stress within the vessel. By accurately simulating these interconnected processes, the framework seeks to facilitate precise performance predictions, while also identifying design parameters and operational regimes that optimize both efficiency and vessel longevity.

Central to the team’s vision is the translation of fundamental physical and chemical principles of hydrogen interaction into computationally efficient predictive models. Dr. Shaat emphasizes the importance of capturing the coupling mechanisms—particularly how hydrogen transport influences thermal and mechanical responses and vice versa—in order to provide reliable simulations that replace and reduce the dependence on lengthy physical testing. This innovative approach promises to significantly reduce costs, accelerate development cycles, and improve hydrogen storage system designs.

On the experimental front, SwRI’s team, under Dr. Fu’s guidance, is undertaking controlled, long-term cycling experiments to collect essential validation data. By subjecting metal hydride vessels to realistic charge-discharge scenarios, they aim to quantitatively monitor performance degradation mechanisms as they unfold. These experiments will provide the empirical backbone necessary to calibrate and refine the modeling framework, ensuring that simulation outputs faithfully represent real-world behavior under operational conditions.

The synergy between modeling efforts and experiments forms the cornerstone of the project’s iterative design loop. As Dr. Fu explains, modeling insights will direct the focus of experimental tests to critical phenomena, while the resulting data will feedback to correct and enhance the models. This dynamic interplay is expected to unravel previously obscure degradation mechanisms by illuminating the coupled chemical, thermal, and mechanical interactions at work within the metal hydride vessels. Ultimately, this feedback-driven methodology will yield a predictive tool capable of guiding material improvements and engineering decisions.

Hydrogen’s emergence as a clean, versatile energy carrier is a key cornerstone of global efforts to decarbonize energy and transportation sectors. However, to fulfill its potential, advances in storage technology are imperative. Unlike batteries or fossil fuels, hydrogen storage demands novel materials and engineering solutions due to its unique physical and chemical characteristics. By focusing on metal hydride vessels, this project addresses a promising yet underdeveloped storage pathway that could unlock safer, more efficient hydrogen deployment across diverse applications.

The S²TAR funding mechanism plays an instrumental role in enabling this interdisciplinary collaboration by providing seed resources that draw on the expertise strengths of both SwRI and St. Mary’s University. This partnership is not only poised to produce high-impact scientific outcomes but also lays the foundation for sustained cooperation. Through this collaboration, the team is well-positioned to attract larger external funding sources from federal agencies and industry players focused on advancing hydrogen infrastructure and clean energy technology.

As work progresses, the team anticipates that their predictive modeling tool will be an invaluable resource for the hydrogen storage community. It will offer designers and researchers an evidence-based platform to evaluate new materials, optimize vessel designs, and predict operational lifetimes with higher confidence. By systematically addressing the core durability challenges of metal hydride storage, this project represents a wide-reaching advancement that could significantly accelerate solid-state hydrogen storage adoption worldwide.

In conclusion, this joint initiative by Southwest Research Institute and St. Mary’s University epitomizes the cutting edge of hydrogen storage research. Through combining rigor in experimental validation and sophistication in physics-based modeling, the project champions a future where hydrogen is stored more safely and efficiently. The knowledge generated here promises to not only rewrite the fundamentals of storage vessel degradation understanding but also to catalyze practical applications in the global hydrogen economy.

---

Subject of Research: Physics-based modeling and experimental validation of TiFe-based metal hydride hydrogen storage vessel degradation and durability.

Article Title: Advancing Solid-State Hydrogen Storage: Predictive Modeling and Experimental Synergy for Metal Hydride Vessel Durability

News Publication Date: June 24, 2026

Web References: https://www.swri.org/markets/energy-environment/power-generation-utilities/advanced-power-systems/hydrogen-energy-research?&utm_medium=referral&utm_source=eurekalert!&utm_campaign=s2tar-metal-hydrides-pr

Image Credits: Southwest Research Institute

Keywords

Hydrogen storage, metal hydrides, TiFe alloys, chemisorption, physics-based modeling, thermo-mechanical framework, hydrogen diffusion, phase transformation, performance degradation, solid-state hydrogen storage, experimental validation, multiphysics simulations

In a groundbreaking study poised to reshape the landscape of inflammatory bowel disease (IBD) treatment, researchers at the University of Louisville have elucidated the molecular mechanisms by which a natural metabolite derived from dietary sources orchestrates a protective immune response in the gut. IBD, encompassing debilitating conditions such as Crohn’s disease and ulcerative colitis, affects millions globally and is characterized by persistent inflammation and compromised intestinal barrier integrity. The intestinal barrier plays a critical role in maintaining homeostasis by allowing nutrient absorption while preventing the translocation of harmful microbial agents. In patients with IBD, this barrier is disrupted, leading to exacerbated inflammation and tissue injury.

Central to this new discovery is urolithin A (UroA), a microbial metabolite produced in the human gut following the ingestion of ellagitannin-rich foods such as pomegranates, walnuts, and berries. The research team led by Dr. Venkatakrishna Rao Jala unveiled how UroA selectively activates the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor expressed in various cell types, including those that constitute the intestinal epithelium. Unlike conventional views of AHR as a mediator of toxicological responses to environmental contaminants, this study highlights a nuanced role for AHR signaling in immune modulation and barrier function maintenance.

In their experimental design, investigators employed a combination of cell culture models, intestinal organoids, and human tissue samples from IBD patients to delineate the cellular and molecular pathways engaged by UroA. This comprehensive approach allowed them to pinpoint intestinal epithelial cells as the primary sites of AHR activation by UroA. Activated epithelial AHR, in turn, stimulates the assembly of the NLRP6 inflammasome, a multiprotein complex traditionally associated with inflammatory cytokine maturation and pyroptotic cell death. Contrary to the canonical inflammatory paradigm, NLRP6 activation here initiates a controlled release of protective mediators that promote epithelial repair, mucus production, and antimicrobial peptide secretion, collectively enhancing barrier integrity.

This dualistic nature of inflammasome signaling reveals an elegant example of cellular context-determined outcomes of innate immune pathways. While systemic inflammasome activation is linked to pathological inflammation, its epithelial-specific engagement appears to serve as a homeostatic mechanism preserving mucosal immunity and preventing microbial dysbiosis. This insight furthers our understanding of the immune microenvironment in the gut and challenges existing dogmas that broadly classify inflammatory signaling as detrimental in chronic intestinal diseases.

The exploration of UroA’s mechanism also sheds light on the intricacies of diet-microbiota-host interactions that underpin gut health. Dietary metabolites have emerged as critical modulators of signaling networks that maintain tissue equilibrium. This study positions urolithin A as a pivotal molecular bridge linking dietary intake to cellular defense strategies, mediated through receptor-mediated inflammasome activation. By elucidating this axis, the findings offer a compelling rationale for dietary or microbiota-targeted interventions designed to harness endogenous metabolites for therapeutic benefit.

Importantly, the protective pathway abrogates damage caused by intestinal injury without invoking broad immunosuppression, a common drawback of current IBD therapies that can predispose patients to infections and malignancies. Targeted activation of epithelial AHR by UroA selectively augments mucosal barrier function while modulating local immunity, offering a precision medicine approach with potentially fewer side effects.

From a translational perspective, these insights could catalyze the development of novel therapeutics that mimic or potentiate UroA’s activity, aiming to restore gut barrier homeostasis in individuals suffering from IBD and other gastrointestinal disorders. Unlike systemic immunomodulators, such agents could enhance intrinsic repair mechanisms, reinforcing the mucosal shield against microbial translocation and inflammation relapse.

Furthermore, this research underscores the importance of endothelial and epithelial cellular compartments in orchestrating immune responses that are finely tuned to environmental and nutritional cues. The aryl hydrocarbon receptor emerges as a nodal point integrating extrinsic and intrinsic signals, modulating inflammasome dynamics uniquely in epithelial cells as opposed to immune cells such as macrophages or dendritic cells, where AHR activation may produce opposing outcomes.

The team’s validation using human intestinal biopsies strengthens the clinical relevance of their findings, demonstrating that UroA-induced AHR-NLRP6 activation is not merely an experimental artifact but a genuine biological phenomenon with implications in human disease states. The investigation also highlights the potential inter-individual variability in microbiota capacity to generate UroA, which may influence susceptibility or response to treatment in IBD patients.

Concluding remarks from the lead investigators emphasize the broader implications of delineating this pathway. By distinguishing harmful from beneficial inflammatory cascades, the study advocates for selective immunomodulation strategies that leverage inherent protective mechanisms instead of indiscriminate suppression. This paradigm shift could revolutionize therapeutic approaches, fostering better clinical outcomes and improved quality of life for those affected by chronic intestinal inflammation.

Collectively, these findings mark a significant advance in gut immunology and open new avenues for precision dietary-based therapeutics. The interaction between diet-derived microbial metabolites, host epithelial signaling, and inflammasome activation represents a complex yet promising frontier in combating chronic inflammatory diseases. As our understanding deepens, integrating nutritional sciences with immunopharmacology may yield innovative treatments that redefine gut health maintenance.

Subject of Research: Human tissue samples

Article Title: Urolithin A activates aryl hydrocarbon receptor-NLRP6-mediated pathways in intestinal epithelial cells to modulate mucosal immunity and strengthen gut barrier integrity

News Publication Date: 23-Jun-2026

Web References: http://dx.doi.org/10.1038/s41467-026-73760-3

References: Published in Nature Communications

Image Credits: University of Louisville

Keywords: Human gut microbiota, Metabolism, Metabolomics, Metabolites, Diseases and disorders, Digestive disorders, Inflammatory bowel diseases, Gastrointestinal tract, Gastrointestinal disorders, Inflammasomes

Deep within the labyrinthine caves of northeastern Mexico dwells a remarkable species of fish, the blind Mexican cavefish (Astyanax mexicanus), whose evolutionary journey over hundreds of thousands of years has led it to adapt to a life shrouded in perpetual darkness. This fish has lost its eyes and pigmentation, hallmark traits of cave-dwelling organisms, while simultaneously acquiring a suite of physiological and behavioral adaptations tailored to survive in nutrient-scarce subterranean environments. Its dual existence as both a sighted surface fish and numerous independently evolved cave forms presents a unique biological system for examining how extreme environments drive evolutionary changes in brain structure, sensory processing, and behavior.

Researchers from Florida Atlantic University, collaborating with experts from institutions across the United States, have leveraged cutting-edge genetic and imaging technologies to decipher the neural underpinnings that distinguish cavefish from their surface relatives. By employing genetically engineered lines of this species that express fluorescent markers in their neurons, the scientists conducted real-time, whole-brain imaging at cellular resolution, unveiling intricate patterns of neural activity in response to sensory stimuli. This approach allowed direct comparison of neural circuitry when fish were exposed to alternating light and dark conditions, providing profound insights into how evolution recalibrates brain function to orchestrate behavior appropriate for radically different environments.

The study, recently published in Science Advances, reveals an astonishing reversal in sensorimotor behavior between the two ecotypes. Whereas surface fish exhibit increased locomotor activity upon sudden darkness—presumably an adaptive mechanism to enhance exploration for light sources—the cavefish respond inversely, with heightened activity triggered by light exposure. This counterintuitive response is theorized to serve as an adaptive avoidance strategy, steering cavefish away from illuminated cave entrances where predation risk and environmental fluctuations are higher. Such behavioral rewiring exemplifies how neural circuits can be evolutionarily repurposed rather than completely reinvented.

Central to this behavioral dichotomy is the alteration of activity within the posterior tuberculum, a brain region long implicated in sensorimotor integration and motivational states. The researchers identified not only region-specific shifts in activity patterns but also characterized a previously undescribed neuronal cell type that appears to play a pivotal role in mediating light-evoked responses. Intriguingly, neurons that in surface fish were activated by darkness exhibited robust activation in cavefish under light stimulus, underscoring the concept of evolutionary neural circuit reutilization. This finding challenges conventional assumptions that new behaviors necessitate de novo neural architectures and instead supports a model where existing circuits are modified to generate novel functional outputs.

Further mechanistic insights emerged from the investigation of dopaminergic signaling pathways. Dopamine, a neurotransmitter extensively involved in motor control, reward processing, and sensory modulation across vertebrates, was found to be centrally implicated in mediating these light-driven behavioral shifts. The study demonstrates that evolutionary tuning of dopamine circuits underlies the behavioral adaptation in cavefish, representing a conserved neurochemical axis modified through natural selection. This work sheds light on the plasticity and evolutionary potential of neuromodulatory systems in shaping species-specific behaviors.

These findings have significant implications beyond the realm of evolutionary biology. Since dopaminergic circuits are highly conserved from fish to mammals, understanding how these systems adapt to environmental pressures provides a window into fundamental brain functions relevant to health and disease. For example, alterations in dopamine signaling underlie numerous neurodevelopmental and neurodegenerative disorders in humans, including Parkinson’s disease, schizophrenia, autism spectrum disorders, and attention deficit hyperactivity disorder (ADHD). By elucidating natural mechanisms of dopamine circuit modification, this research may inform therapeutic strategies targeting related pathologies characterized by dysregulated sensory processing and motor responses.

The genetically controlled inheritance of photokinetic behavior further underscores the robustness of these adaptations. Crossbreeding experiments between surface fish and cavefish yielded hybrid offspring exhibiting a spectrum of activity responses to light and dark, confirming that these sensorimotor traits are encoded within the genome. Dissecting the genetic loci and developmental pathways responsible for remodeling neural circuits remains a crucial next step. Such investigations promise to unravel molecular drivers of behavioral evolution and highlight how genetic variation translates into neural and behavioral diversity.

The blind Mexican cavefish stands as an exemplary model system to probe how sensory systems are sculpted by evolutionary forces and how brains dynamically reconfigure to interpret environmental signals. By disentangling the neural rewiring that facilitates survival in total darkness, researchers gain a clearer picture of how sensory inputs are transformed into adaptive motor outputs. This contributes to a broader understanding of brain evolution applicable across vertebrates and illustrates nature’s ingenuity in leveraging existing neural frameworks to solve complex ecological challenges.

Through advanced imaging and behavioral quantification, the Florida Atlantic University team has carved new ground in charting the neural circuit modifications that underpin a dramatic shift from dark-evoked to light-evoked photokinesis. This work provides a compelling paradigm illustrating that evolution does not invariably mandate the invention of novel structures but can preferentially repurpose and recalibrate pre-existing neural substrates to generate behavioral novelty.

The evolutionary narrative of the blind Mexican cavefish enriches our comprehension of neuroecology—the study of how nervous systems evolve in response to environmental variables. It reveals that sensory deprivation, far from being a mere loss, can instigate intricate neural and behavioral innovations that confer selective advantages. Such insights deepen our appreciation for the complexity and flexibility inherent in neural systems when confronted with extreme ecological niches.

Finally, this research exemplifies the power of integrative methodologies combining genetics, neurobiology, and behavioral science to unravel the enigma of brain evolution. It paves the way for future interdisciplinary studies to identify specific genes orchestrating neural circuit plasticity, decode developmental mechanisms driving neuronal subtype specification, and ultimately connect genotype to phenotype in a context of evolutionary adaptation.

---

Subject of Research: Animals

Article Title: Evolution of a central dopamine circuit underlies adaptation of a light-evoked sensorimotor response in the blind cavefish

News Publication Date: 22-May-2026

Web References:
DOI: 10.1126/sciadv.adv3770

Image Credits: Florida Atlantic University

Keywords: Evolutionary biology, Brain, Neurons, Sensory neurons, Photoreceptors, Neurological disorders, Neurodegenerative diseases, Parkinson’s disease, Schizophrenia, Fish, Brain activity maps, Behavioral ecology, Ecological adaptation, Neural pathways, Dopamine pathways

In a groundbreaking longitudinal study encompassing nearly half a million individuals, researchers have unveiled intricate patterns and biological underpinnings that link cardiometabolic diseases (CMDs) and depression. These two prevalent and often coexisting health conditions have long posed challenges due to their complex interaction and compounded risk on mortality. Now, through a multinational, multi-omic analytic approach, this study sheds new light on how these diseases develop, interlace over time, and ultimately impact life expectancy, offering hope for earlier detection and more precise interventions.

Cardiometabolic diseases—which include chronic conditions such as cardiovascular disease, type 2 diabetes, and metabolic syndrome—are among the leading causes of death globally. Depression, meanwhile, remains a colossal mental health burden, often running parallel to various physical ailments. The coexistence, or multimorbidity, of CMDs and depression exacerbates health outcomes significantly, yet the trajectory of how one condition progresses to include the other and the biological mechanisms driving this interaction have remained elusive.

Leveraging data from the UK Biobank, the largest population-based health cohort, the study followed 467,592 participants initially free of both CMD diagnoses and depression. Over a 14.6-year period, the scientists meticulously chronicled disease transitions using advanced multistate models. These allowed them not only to identify disease onset patterns but also to map complex pathways outlining progression from health to single disease states and then to multimorbidity.

The findings revealed that within the follow-up window, more than 64,000 participants developed CMD alone, while approximately 17,500 were diagnosed with depression exclusively. Crucially, over 6,100 individuals progressed to multimorbidity, reflecting the convergence of these conditions in a significant subset of the population. Importantly, the risk of subsequently developing the alternate condition was substantially elevated for those already affected by either CMD or depression, underscoring the bidirectional relationship between physical and mental health.

Further delving into survival outcomes, the researchers observed that individuals with multimorbidity faced a 13 to 22 percent increase in mortality risk compared to those free of disease, accompanied by a marked reduction in life expectancy averaging between 3.6 to 3.8 years. Such stark contrasts reinforce the clinical urgency of understanding and managing the intersection of CMDs and depression rather than treating them in isolation.

However, a nuanced discovery emerged from the survival analysis: the mortality impact of coexisting CMD and depression appeared additive rather than synergistic. This suggests that while coexistence heightens risk, the two diseases may operate through largely independent pathways driving mortality, a revelation that could recalibrate how treatment priorities are structured.

To decipher biological signatures predictive of disease progression and multimorbidity, the study incorporated multi-omics platforms—comprehensive analyses including proteomics, metabolomics, genomics, and methylomics. These high-dimensional tools allow scientists to detect subtle molecular changes reflecting pathophysiological shifts and prognostic biomarkers far earlier than clinical symptoms emerge.

Remarkably, proteomic models stood out in their predictive prowess. When applied to the 15-year risk horizon for CMD-depression transitions, these models achieved area-under-the-curve (AUC) values ranging between 0.70 and 0.91. This performance significantly eclipsed that of traditional clinical risk models, heralding a new dawn where molecular profiling could transform risk stratification and preventive strategies.

Distinct multi-omic signatures were identified at each disease transition point—whether from health to CMD alone, health to depression alone, or the combined pathway leading to multimorbidity. These signatures could reflect unique biological processes such as inflammatory cascades, metabolic dysregulation, neuroendocrine changes, or immune system perturbations, each contributing distinctively to disease progression.

The implications of these findings are far-reaching. With multimorbidity presenting as a growing global health challenge, understanding its trajectory and molecular footprints empowers clinicians and researchers to design targeted interventions that transcend symptom management. Early identification of individuals at highest risk via omic biomarkers could enable precision medicine approaches that pre-empt illness onset or halt progression.

Furthermore, by elucidating the distinct yet interconnected biological pathways linking CMDs and depression, this research challenges the traditionally siloed view of mental and physical health. It advocates for integrated care models that address the whole person rather than fragmented disease entities, a paradigm shift essential for improving patient outcomes in real-world settings.

The study also leverages rigorous multistate modeling, a sophisticated statistical technique allowing for dynamic representation of illness progression over time. This approach captures the complexity inherent in chronic disease trajectories, encompassing not only onset but transitions between disease states and eventual mortality. Such modeling enhances the granularity of epidemiological insights far beyond conventional methods.

As large-scale biobanks increasingly incorporate multi-omic data, the ability to unravel disease biology at unprecedented depth will only grow. The present study exemplifies how marrying big data with cutting-edge analytic frameworks can unveil novel insights into multimorbidity, transforming epidemiology into a powerful tool for precision health.

This research arrives at a critical juncture where global populations face rising burdens of chronic diseases intertwined with mental health challenges. Targeted, biologically informed strategies could ease the strain on healthcare systems and improve quality of life for millions living with overlapping disease burdens.

While promising, the findings also urge cautious optimism. The translation of molecular signatures into routine clinical tools requires further validation and contextualization across diverse ancestral and environmental backgrounds. However, these initial steps firmly establish a conceptual blueprint for future studies to build upon.

Taken together, this extensive investigation pioneers a new frontier in understanding the intertwined evolution of cardiometabolic diseases and depression. By uniting longitudinal clinical data with multi-omics analyses and sophisticated modeling, it heralds a transformative approach toward unraveling multimorbidity’s mysteries and paves the way for early, targeted prevention.

The convergence of CMDs and depression, previously viewed as a devastating clinical overlap, now emerges as a tractable problem awaiting targeted intervention—fueling hope that integrated molecular insights will soon translate into lifesaving real-world applications. This revolutionary research sets the stage for a future where vulnerability to complex chronic disease is revealed well before symptoms arise, opening unprecedented avenues for personalized health preservation.

Subject of Research:
Multi-omic signatures and disease trajectories linking cardiometabolic diseases and depression

Article Title:
Multi-omic signatures and trajectories of cardiometabolic diseases and depression

Article References:

Yang, G., Jiang, X., Wang, J. et al. Multi-omic signatures and trajectories of cardiometabolic diseases and depression.
Nat. Mental Health (2026). https://doi.org/10.1038/s44220-026-00678-6

Image Credits: AI Generated

DOI:
https://doi.org/10.1038/s44220-026-00678-6

Commercial space station company Vast announced June 24 the addition of several companies and organizations to its network of partners for microgravity research and manufacturing.

The post Vast signs additional partners for commercial space station microgravity research appeared first on SpaceNews.

Experiments exploring the effects of missing a night’s sleep on the human brain have found indications that a sleepless night actually increases connections between brain cells instead of impeding growth. However, the lack of sleep could also create brain “fatigue” and pressure, resulting in burnout.

The Forschungszentrum Jülich Institute of Neuroscience and Medicine team behind the discovery said that their findings might support the idea that sleep plays an important role in restoring the brain’s cellular balance.

Missing a Night’s Sleep Could Disrupt Cellular Balance

In a statement announcing the surprising discovery, study leader David Elmenhorst and colleagues note that scientists still are not in complete consensus about why humans and other animals need sleep. One proposal involves restoring synaptic connections between brain cells during certain stages of sleep, helping the brain maintain a form of cellular ‘homeostasis.’

For example, previous research has shown that synaptic connectivity increases during wakefulness. This increased activity also increases energy consumption, potentially resulting in problematic protein buildup. Conversely, scientists suspect that sleep helps restore baseline synaptic connections and protein levels, thereby maintaining a healthy cellular balance.

“Sleep is essential for synaptic homeostasis, a proposed mechanism whereby wake­fulness leads to synaptic potentiation, and sleep facilitates synaptic down-selection,” the research team explains in a recently published study.

Although previous studies suggest that missing a night’s sleep could disrupt this balance, the team notes that there is very little experimental data to support these conclusions.

Study Reveals Elevated Synaptic Activity After 28 Hours Awake

To explore the role of sleep in cellular homeostasis in the human brain, the researchers used an advanced brain-scanning technology called positron emission tomography (PET). According to the team’s statement, this tool can scan the human brain for signs of synaptic vesicle glycoprotein 2A (SV2A),  which they describe as a “marker” of brain synapses.

The team started by enlisting 40 study volunteers. Next, each volunteer was given a PET scan to establish baseline marker levels. After their first scan, 20 of the volunteers were told to get a normal night’s sleep. According to the study authors, the second half were assigned to “the sleep deprivation condition,” where they were told to miss a night’s sleep.

The next day, the team used the PET scan to search for telltale brain synapse markers. As hoped, the scans revealed a distinct difference between the two groups. Where the normal sleep group’s levels were within expected ranges, the synapse markers of the volunteers who had missed a night’s sleep were elevated.

A closer analysis found that once people passed 28 hours of continued wakefulness, their SV2A markers were higher “in several brain regions.” Notably, these increased markers were detected in the hippocampus, which plays an important role in memory, and in the thalamus, which is critical for information relay within the brain.

“Sleep deprivation led to significant increases in synaptic vesicle glycoprotein 2A binding in multiple brain regions, including the thalamus (+4.6%), hippocampus (+5.6%), and parietal cortex (+3.2%), whereas no changes were observed in controls,” the study authors write.

Sleep Deprivation Causes Fatigue and CHanges Neural COnnections

When discussing the study’s limitations, the authors note that the SV2A marker used is a “proxy” for connections between brain cells, not a direct measure. They also note that the observed changes after a missed night’s sleep “were relatively small.” Still, they add, the results in several regions across several study participants “suggest a biological connection between the need for sleep and the buildup of cell connections.”

“During sleep deprivation, the brain remains awake longer and continues to process stimuli and information,” they write. “Our study shows that after approximately 28.5 hours of wakefulness, a marker for synaptic density increases in several brain regions. This suggests that sleep deprivation not only causes fatigue but is also accompanied by measurable changes in neural connections.”

The study “Sleep deprivation increases levels of the synaptic density marker SV2A in the human brain” was published in PLOS Biology.

Christopher Plain is a Science Fiction and Fantasy novelist and Head Science Writer at The Debrief. Follow and connect with him on X, learn about his books at plainfiction.com, or email him directly at christopher@thedebrief.org.

A groundbreaking study led by researchers at the University of Southern California (USC) has revealed that Alzheimer’s disease and related dementias are projected to impose an astronomical economic burden on the United States in 2026, amounting to an estimated $818 billion. This figure eclipses prior estimates as it incorporates often overlooked and nuanced costs, including the significant toll on the quality of life for those living with dementia and the substantial unpaid care provided by family members and friends. This comprehensive accounting reshapes our understanding of dementia’s societal impact, underscoring the urgency of policy innovation and resource allocation.

Traditional assessments of dementia’s economic footprint have primarily focused on direct medical and long-term care expenses. However, this USC study breaks new ground by adopting a holistic approach that integrates broader social and economic dimensions. The model includes quality of life diminishment for patients and informal caregivers, loss of income due to both the disease and caregiving responsibilities, and the extensive, unpaid labor carried out by millions of family members — a demographic often in their prime working years. This multifaceted approach allows for a more accurate reflection of the real costs dementia inflicts on society.

The study’s authors estimate that approximately 5.7 million Americans will be living with dementia in 2026, with 5.1 million of these individuals aged 65 and over. This demographic shift drives the increasing financial demands on healthcare systems and families alike. More crucially, the profound cognitive and functional decline experienced by dementia sufferers translates to a staggering $320 billion in lost quality of life, representing the single largest cost category. Care partners, often emotionally and physically strained, suffer quality-of-life costs valued at an additional $15 billion, quantifying the invisible burden that has been historically underestimated.

Unpaid caregiving, a cornerstone of dementia support, amounts to an astonishing 6.8 billion hours annually, contributed by approximately 5.2 million unpaid caregivers. This contribution is monetized at $237 billion, illustrating the massive economic value of informal care networks sustaining individuals with dementia. Long-term medical care, which includes nursing homes, home health services, and medical treatments, is projected at $222 billion. Medicare and Medicaid programs are shoulder approximately 70% of these costs, creating fiscal pressures on public health financing, while families and patients face out-of-pocket expenses near $46 billion—a significant financial stressor for many households.

Furthermore, the study incorporates lost wages, quantifying foregone earnings of $23 billion for both individuals living with dementia and their unpaid caregivers. These labor market impacts have wide-ranging implications for household financial stability and overall economic productivity. By deploying a dynamic microsimulation modeling framework and leveraging large nationally representative datasets—such as the Health and Retirement Study and administrative data from Medicare and Medicaid—the researchers have crafted a data-driven lens through which to forecast future dementia costs under various clinical and policy scenarios.

This evolving cost model is significant not only for its predictive power but for its potential to inform decision-making at multiple levels. It integrates peer-reviewed methodologies, published in a dedicated methods paper that ensures transparency in data sources, assumptions, and simulations. This methodological rigor equips policymakers, healthcare providers, and researchers with a robust platform to interrogate the efficacy of emerging treatments, changes in care delivery models, and evolving health policies. The goal is to better understand how these innovations might shift dementia’s economic and social impact.

The USC-led team’s interdisciplinary composition enhances the study’s depth and applicability. Contributors hail from diverse academic units within USC—including the Price School of Public Policy, the Mann School of Pharmacy and Pharmaceutical Sciences, the Davis School of Gerontology, and the Viterbi School of Engineering—as well as esteemed external collaborators from the Alzheimer’s Association and the University of Pennsylvania. This collaboration has generated a model enriched by real-world insights from people with mild cognitive impairment and their care partners, gathered through Alzheimer’s Association panels. Their lived experiences add critical context often absent from purely quantitative analyses.

In parallel with advances in medical science, this research dovetails with promising trends in dementia detection and management. FDA-approved blood tests now allow for the pre-symptomatic identification of Alzheimer’s pathology, while emerging therapeutics show potential in slowing disease progression. Innovative care models focused on keeping individuals at home for longer durations while supporting family caregivers further signal a paradigm shift in dementia care. This study’s comprehensive cost framework can serve to evaluate the economic and societal ripple effects of such innovations, offering a valuable forecasting tool amid the rapidly changing landscape.

Lead researcher Julie Zissimopoulos emphasizes that accurate, comprehensive cost assessments are vital for allocation of resources in the face of a growing dementia population. This modeling approach allows for simulations that address critical questions, such as how slow-progressing treatments could improve quality of life or reduce nursing home demand, yielding insights needed for smarter, evidence-based policymaking. For example, understanding potential reductions in caregiving burden or shifts in out-of-pocket expenses can guide investment priorities across public health and social services sectors.

Moreover, the dynamic microsimulation approach employed by the study captures longitudinal impacts on individual trajectories, accounting for how health interventions at earlier disease stages might alter future care needs and economic costs. By continuously updating the model with new data inputs and methodological enhancements, the USC team ensures that their projections remain responsive to evolving clinical knowledge and demographic trends, positioning the cost estimates as authoritative inputs for strategic planning.

A particularly striking takeaway is the valuation of informal caregiving, which emphasizes the critical yet underappreciated role family and friends play in sustaining the dementia-affected population. The emotional, physical, and financial strain borne by these caregivers often goes unrecognized in policy dialogues. Quantifying these costs helps to illuminate the hidden layers of dementia’s societal toll, strengthening the argument for supportive interventions, caregiver resources, and systemic reforms to alleviate their burden.

Dana Goldman, founding director of the USC Schaeffer Institute, highlights that understanding the expanding economic footprint of dementia is fundamental to harnessing the full potential of scientific and care innovations. As Alzheimer’s disease and related dementias continue to challenge health systems globally, this study outlines a crucial framework for evaluating the interplay between emerging therapeutics, care delivery, and economic sustainability. It advocates for data-driven policies that adapt to and capitalize on these transformative changes.

This comprehensive analysis of dementia’s economic burden thus represents a critical step forward in the public health and policy arenas. Its nuanced incorporation of quality-of-life metrics, unpaid caregiving, lost earnings, and formal healthcare expenses paints a detailed portrait of the multifaceted costs dementia imposes. As American society confronts a rapidly aging population, these findings serve as a clarion call to address the broad spectrum of dementia’s impact, ensuring informed strategies to mitigate its profound human and economic consequences.

---

Subject of Research: Economic Impact of Alzheimer’s Disease and Related Dementias
Article Title: The 2026 U.S. Cost of Dementia: A Comprehensive Model Accounting for Quality of Life and Informal Caregiving
News Publication Date: 24 June 2026
Web References: https://schaeffer.usc.edu/cost-of-dementia-model/; https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.71480
References: Zissimopoulos, J., et al. (2026). Comprehensive cost modeling of Alzheimer’s disease and related dementias. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, doi:10.1002/alz.71480
Image Credits: USC Schaeffer Center for Health Policy & Economics

Keywords: Dementia, Alzheimer’s disease, Economic burden, Quality of life, Informal caregiving, Health care costs, Lost wages, Policy modeling, Aging population, Health economics, Microsimulation

In a groundbreaking study published in Cell Death Discovery, researchers have unveiled a novel mechanism by which Helicobacter pylori, the notorious gastric pathogen, drives the formation and persistence of gastric cancer through a process termed the “hit-and-run” legacy. This research elucidates how transient infection by H. pylori delivers a lasting epigenetic imprint on gastric epithelial cells, effectively locking these cells into a survival mode that fosters oncogenesis. The implications of these findings are profound, offering fresh insights into the molecular interplay between infection-induced epigenetic modification and cancer development, which could pave the way for revolutionary diagnostic and therapeutic strategies.

Helicobacter pylori has long been established as a principal carcinogen associated with gastric cancer, a malignancy ranking among the world’s deadliest. Traditionally, the carcinogenic potential of H. pylori has been attributed to chronic inflammation and the persistent presence of bacterial virulence factors that continuously disrupt gastric mucosa homeostasis. However, the current study challenges this paradigm by demonstrating that even transient exposure to H. pylori can induce stable, heritable epigenetic alterations that effectively “lock” the cellular genome into an aberrant state, independent of ongoing infection. This “hit-and-run” mechanism underscores the importance of early, possibly even brief, pathogen-host interactions in cancer genesis.

At the heart of this discovery is the concept of epigenetic locking—a process through which transient signals induce durable modifications in DNA methylation and histone patterns, which subsequently enforce gene expression profiles conducive to cell survival and proliferation. The group led by Sun, Hu, and Traub employed state-of-the-art genome-wide methylation profiling alongside chromatin immunoprecipitation sequencing (ChIP-seq) to map the intricate epigenetic landscapes shaped by H. pylori infection. Their findings revealed a marked enrichment of repressive histone marks on tumor suppressor gene loci and a reduction in methylation at key oncogenic enhancers, a dual mechanism that effectively enables gastric epithelial cells to bypass apoptosis and adopt a resilient phenotype.

Intriguingly, the authors identified a “survival switch” embedded within the epigenetic circuitry, which perpetuates cell viability in the hostile gastric environment despite the absence of the pathogen. This survival pathway hinges on the modulation of several critical transcription factors and downstream effectors that drive resistance to oxidative stress and immune checkpoint evasion. The persistence of this switch presents a formidable barrier to therapeutic intervention, explaining the often-observed resistance and relapse seen in conventional anti-H. pylori and chemotherapeutic regimes.

The study further explores the timing and sequence of epigenetic alterations following H. pylori infection. Temporal analysis demonstrated that initial infection triggers a wave of epigenetic remodeling within days, with key changes becoming fixed in the genome over weeks, thus confirming the durability of the modifications. This rapid “imprinting” emphasizes the need for early detection and intervention post infection to prevent the establishment of irreversible oncogenic programs.

Mechanistically, the team delved into the role of bacterial virulence factors such as CagA and VacA in orchestrating these epigenetic changes. They postulate that CagA, upon translocation into host cells, interacts with host chromatin modifiers and signaling pathways like NF-kB and STAT3, initiating cascades that culminate in altered chromatin architecture. VacA further modulates cellular metabolism and stress responses, cumulatively fixing the epigenetic landscape conducive to cancer progression.

The implications of the “hit-and-run” model extend beyond H. pylori-induced gastric cancer, provoking reconsideration of how transient infections may contribute to other epigenetically driven malignancies. This paradigm shift advocates for a broader investigation into the long-term impact of infectious insults at the epigenome level, potentially revolutionizing the standard view of tumorigenesis associated with microbial pathogens.

Therapeutically, the study stimulates the development of epigenetic-targeted approaches aimed at “unlocking” these stable aberrations. By reversing methylation patterns or disrupting the survival networks sustained by epigenetic modifications, it may become possible to sensitize tumor cells to existing chemotherapies or to immune-mediated clearance. The prospect of integrating epigenetic therapy into the clinical management of H. pylori-associated gastric cancer represents a promising frontier.

Moreover, diagnostic innovation could also benefit from these findings. Epigenetic biomarkers identified through this research may serve as early indicators of cancer risk in patients with a history of H. pylori infection, enabling stratification and personalized surveillance. The early detection of epigenetic locking signatures in gastric mucosa could dramatically improve prognosis by facilitating timely therapeutic intervention.

The study’s comprehensive exploration of epigenetic changes was bolstered by the use of gastric organoids and in vivo models, which authentically recapitulated the cellular and tissue contexts of H. pylori infection. This multi-faceted experimental design lent robust physiological relevance to the findings and highlighted the dynamic interplay between pathogen factors and host epigenomic machinery.

Collectively, this research not only deciphers the cryptic molecular legacy left by H. pylori but also refines our understanding of infection-associated carcinogenesis. The “hit-and-run” legacy paradigm sheds light on the complex, often covert, mechanisms through which transient pathogen interactions exert long-lasting oncogenic effects, shifting both scientific insight and clinical approach.

In summary, the work by Sun, Hu, Traub, and colleagues heralds a new era in gastric cancer biology, emphasizing the critical role of infection-driven epigenetic programming. As further investigations build upon this foundation, multidisciplinary efforts encompassing microbiology, epigenetics, and cancer therapeutics will be essential to translate these insights into tangible clinical applications.

The future of combatting H. pylori-associated gastric cancer lies not only in eradicating the bacteria but also in decoding and reversing the epigenetic codes it inscribes. This endeavor carries the promise of transforming patient outcomes, potentially mitigating one of the world’s most lethal cancers with strategies born from the understanding of the pathogen’s epigenetic “hit-and-run” legacy.

---

Subject of Research: Epigenetic mechanisms underlying the persistence and oncogenic transformation in Helicobacter pylori-associated gastric cancer.

Article Title: The “Hit-and-Run” legacy: epigenetic locking and the survival switch in H. pylori-associated gastric cancer.

Article References:
Sun, J., Hu, P., Traub, B. et al. The “Hit-and-Run” legacy: epigenetic locking and the survival switch in H. pylori-associated gastric cancer. Cell Death Discov. (2026). https://doi.org/10.1038/s41420-026-03210-y

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41420-026-03210-y

BenQ’s 4100i projector shines with its amazing color reproduction, excellent contrast, and a buttery cinematic mode.

BenQ’s 4100i projector shines with its amazing color reproduction, excellent contrast, and a buttery cinematic mode.

À l'occasion de sa 10e édition, VivaTech a une nouvelle fois mis à l'honneur les innovations qui façonnent le monde de demain. Du 17 au 20 juin, le salon parisien a réuni les grands noms de l'intelligence artificielle, du spatial et de la tech européenne. Au micro de Futura, Allan Petre est...

Amazon and several other non-geostationary satellite operators have formed a trade association to represent their fast-growing market, with SpaceX notably absent despite having by far the largest NGSO constellation.

The post NGSO trade association launches without industry giant SpaceX appeared first on SpaceNews.

Don't pay full price—snag one of these tasty Prime Day tech deals on some of our favorite WIRED-tested gadgets.

Don't pay full price—snag one of these tasty Prime Day tech deals on some of our favorite WIRED-tested gadgets.

Photographer Shane Hynan explores the tension between the central role peat bogs play in Irish life and their wider environmental impact

“You can read Ireland’s history in the boglands. They hold millennia in their layers,” says photographer Shane Hynan of his project, Beofhód (meaning Beneath in English).

The boglands, known as portachs in Irish, cover roughly 1.2m to 1.5m hectares or about 14% to 17% of the country’s total land area. The raised bogs of the Irish Midlands are made of peat that forms at a rate of 1mm a year (0.04in) in low-lying, poorly drained basins or former lakes. As the historical geographer Kevin Whelan observes in the Atlas of the Irish Rural Landscape, “the bog has been etched as deeply into the human as into the physical record in Ireland – to an extent unrivalled elsewhere.”

Eddie and Con footing turf for domestic use, Knockirr Bog, County Kildare, 2022.

Continue reading...

© Photograph: Shane Hynan

© Photograph: Shane Hynan

© Photograph: Shane Hynan